P-170 glycoprotein (P-170) is involved in the impairment of natural killer cell-mediated cytotoxicity in HIV+ patients

This publication has 14 references indexed in Scilit:

• Analysis of Natural Killer (NK) Cell Subsets Defined by the Expression of Two Novel Surface Antigens (EB6 and GL183) in AIDS and AIDS-Related Conditions
  Clinical Immunology and Immunopathology, 1994
• Diverse multidrug-resistance-modification agents inhibit cytolytic activity of natural killer cells
  Cancer Immunology, Immunotherapy, 1993
• Preferential expression and activity of multidrug resistance gene 1 product (P-glycoprotein), a functionally active efflux pump, in human CD8 + T cells: A role in cytotoxic effector function
  Journal of Clinical Immunology, 1992
• Evidence of a natural killer (NK) cell repertoire for (allo) antigen recognition: definition of five distinct NK-determined allospecificities in humans.
  The Journal of Experimental Medicine, 1992
• Identification of four subsets of human CD3-CD16+ natural killer (NK) cells by the expression of clonally distributed functional surface molecules: correlation between subset assignment of NK clones and ability to mediate specific alloantigen recognition.
  The Journal of Experimental Medicine, 1990
• Specific recognition of human CD3-CD16+ natural killer cells requires the expression of an autosomic recessive gene on target cells.
  The Journal of Experimental Medicine, 1990
• THE BIOCHEMISTRY OF P-GLYCOPROTEIN-MEDIATED MULTIDRUG RESISTANCE
  Annual Review of Biochemistry, 1989
• Specific lysis of allogeneic cells after activation of CD3- lymphocytes in mixed lymphocyte culture.
  The Journal of Experimental Medicine, 1988
• Use of fluorescent dyes as molecular probes for the study of multidrug resistance
  Experimental Cell Research, 1988
• Mechanism of Cytotoxicity by Natural Killer (NK) Cells
  Annual Review of Immunology, 1986